Updated: FDA approves Autolus’ CAR-T cell therapy for aggressive blood cancer

US regulators gave the green light to Autolus Therapeutics’ cell therapy for adult B cell precursor acute lymphoblastic leukemia, or B-ALL, that has returned or …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Fountain Life Acquires LifeOmic to Optimize Preventative Care

What You Should Know: – Fountain Life, a leader in advanced diagnostics and preventative healthcare, has acquired LifeOmic, a health data technology company specializing in

December 6, 2023

TLT stock & TMF stock analysis And why I like TMF Stock over TLT stock right now

August 24, 2023

HHS selects intranasal vaccine candidates for Project NextGen, doles out $500M in funds

HHS on Friday announced its selections for the next-generation of Covid-19 vaccine candidates to receive $500 million in funding as part of the government’s Project

October 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.